Zamira Life Sciences has raised funds
Zamira Life Sciences has completed a fundraising to accelerate growth.
Zamira is focused on providing innovative, research-based solutions to improve the health, well-being and productivity of food-producing animals. Products and services prevent and treat key animal diseases to ensure safe and sustainable food production. They are favorably positioned as a premium brand with localized understanding and expertise – a trusted and strong Australian brand identity amongst its international competitors.
Oaklins’ team in Australia acted as corporate advisor and lead manager to the raise.
Talk to the deal team
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Learn more
IJssel Technologie agrees to sell the company to Argos Wityu
The shareholders of IJssel Technologie have agreed to sell a majority stake in the company to Argos Wityu. By partnering with Argos Wityu, IJssel Technologie welcomes a strong new shareholder that will help strengthen the company’s market-leading position and together will further improve IJssel Technologie’s service offering to address the relevant macro-economic developments, including the trend toward sustainable and smart industries.Learn more
Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital
The shareholders of Brookdale Treeland Nurseries have sold a controlling stake to Rouge River Capital.Learn more